James E Wooldridge - Eli Lilly & Co | 人才画像

基本信息

浏览量：16

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 104 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma: A Prospective Phase II Trial

Diwakar Davar,Robert M. Morrison,Amiran K. Dzutsev,Arivarasan Karunamurthy,Joe-Marc Chauvin, Florent Amatore,Julie S. Deutsch,Rodrigo X. Das Neves,Richard R. Rodrigues,John A. McCulloch,Hong Wang,Douglas J. Hartman,Jonathan H. Badger,Miriam R. Fernandes,Yulong Bai,Jie Sun,Alicia M. Cole, Poonam Aggarwal, Jennifer R. Fang,Christopher Deitrick,Riyue Bao,Umamaheswar Duvvuri,Shaum S. Sridharan,Seungwon W. Kim,Haroon A. Choudry,Matthew P. Holtzman,James F. Pingpank, James Patrick O'Toole,Richelle DeBlasio, Yang Jin,Quanquan Ding,Wentao Gao, Christopher Groetsch,Ornella Pagliano,Amy Rose, Corey Urban,Jagjit Singh,Prajan Divarkar,David Mauro,Dmitri Bobilev,James Wooldridge,Arthur M. Krieg,Matthew G. Fury,Jeffrey R. Whiteaker,Lei Zhao,Amanda G. Paulovich,Yana G. Najjar,Jason J. Luke,John M. Kirkwood,Janis M. Taube,Hyun Jung Park,Giorgio Trinchieri,Hassane M. Zarour

CANCER CELLno. 11 (2024): 1898-+

引用1浏览0WOS引用

Supplementary Data from Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

Antoni Ribas,Theresa Medina,John M. Kirkwood,Yousef Zakharia,Rene Gonzalez, Diwakar Davar,Bartosz Chmielowski, Katie M. Campbell, Riyue Bao,Heather Kelley,Aaron Morris,David Mauro,James E. Wooldridge,Jason J. Luke, George J. Weiner,Arthur M. Krieg, Mohammed M. Milhem

openalex（2023）

引用0浏览0引用

Novel, Engineered, Modified Fcγ Receptor I (Cd64)-Expressing T Cells (solidt) Combined with Rituximab Exhibited Profound Anti-Tumor Activity and Memory in a CD20+ Raji Xenograft Model of Lymphoma

Diana Rasoulouniriana,Hana Shpilt,Shahar Dotan,Noam Pilpel,Peleg Rider,Yaron Carmi,James Wooldridge

BLOOD（2023）

引用0浏览0引用

Supplemental Table 1 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma

Noopur S. Raje,Edward A. Faber,Paul G. Richardson,Gary Schiller,Raymond J. Hohl,Adam D. Cohen,Andres Forero,Susan Carpenter,Tuan S. Nguyen,Ilaria Conti,Christopher J. Kaiser,Damien M. Cronier,James E. Wooldridge,Kenneth C. Anderson

openalex（2023）

引用0浏览0引用

Supplementary Tables 1-3 from A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), As Monotherapy and in Combination with Erlotinib in Advanced Cancer

Lee S. Rosen,Jonathan W. Goldman,Alain P. Algazi,P. Kellie Turner,Brian Moser,Tianle Hu,Xuejing Aimee Wang,Jay Tuttle,Volker Wacheck,James E. Wooldridge,Michaela Banck

openalex（2023）

引用0浏览0引用

Supplemental Table 3 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma

openalex（2023）

引用0浏览0引用

Supplementary Tables 1-4 from Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

Andres Forero-Torres,Sven de Vos,Brad L. Pohlman,Maksim Pashkevich,Damien M. Cronier,Nam H. Dang,Susan P. Carpenter,Barrett W. Allan, James G. Nelson,Christopher A. Slapak,Mitchell R. Smith,Brian K. Link,James E. Wooldridge,Kristen N. Ganjoo

openalex（2023）

引用0浏览0引用

Supplementary Figure 1B from A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), As Monotherapy and in Combination with Erlotinib in Advanced Cancer

Lee S. Rosen,Jonathan W. Goldman,Alain P. Algazi,P. Kellie Turner,Brian Moser,Tianle Hu,Xuejing Aimee Wang,Jay Tuttle,Volker Wacheck,James E. Wooldridge,Michaela Banck

openalex（2023）

引用0浏览0引用

Supplemental Table 2 from Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma

openalex（2023）

引用0浏览0引用

Supplemental Figures from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth

Mark D. Badeaux,Annah S. Rolig,Giulia Agnello,Danlee Enzler,Melissa J. Kasiewicz,Leslie Priddy,Jason F. Wiggins,Alexander Muir,Mark R. Sullivan,Jessica Van Cleef,Christopher Daige,Matthew G. Vander Heiden,Venkatesh Rajamanickam,James E. Wooldridge,William L. Redmond,Scott W. Rowlinson

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn